Center for Global Health R&D Policy Assessment

Follow us on:

Much Ado about NCDs, but what about R&D?

What is the role of R&D in addressing non-communicable diseases in developing countries?

This is a joint post with Aarthi Rao.

Since our interview with Phillip Baker from NCD Alliance, there has been much discussion in the global health community about the growth of non-communicable diseases (NCDs) in developing countries.

What can we do about non-communicable diseases (NCDs)?

An Interview with Phillip Baker from NCD Action Network to find out more about NCDs and what the R&D community can do

NCD Action Network Logo

Previously, we wrote about this year’s annual Global Health Council Conference and its focus on non-communicable diseases (NCDs). We mentioned the profound global economic impact of NCDs and asked the global health research and development (R&D) community what we can do to address the issue of NCDs.

We decided to take a closer look at NCDs—to understand the basics of NCDs and to explore opportunities that exist for R&D.

Global Health Council Conference: Addressing Non-Communicable Diseases

The focus on NCDs at the GHC Conference and what the R&D community can do

The undercurrent of this year’s annual Global Health Council Conference, “Securing a Healthier Future in a Changing World” is the growing challenge of addressing non-communicable diseases (NCDs) in low- and middle-income countries (LMICs).

The opening plenary reinforced the urgency of this problem—Dr. Felicia Knaul of the Harvard Medical School noted that 80% of preventable cancer deaths occur in low and middle income countries. Statistics for other NCDs, such as diabetes and cardiovascular disease, tell a similar story.